Jeff Chiprin - 11 Dec 2025 Form 4 Insider Report for IRADIMED CORP (IRMD)

Role
Chief Commercial Officer
Signature
/s/ Jeff Chiprin
Issuer symbol
IRMD
Transactions as of
11 Dec 2025
Net transactions value
-$30,090
Form type
4
Filing time
12 Dec 2025, 17:00:21 UTC
Previous filing
13 Dec 2024
Next filing
05 Mar 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Chiprin Jeff Chief Commercial Officer C/O IRADIMED CORPORATION, 12705 INGENUITY DRIVE, ORLANDO /s/ Jeff Chiprin 12 Dec 2025 0002047489

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IRMD Common Stock Options Exercise +996 996 11 Dec 2025 Direct F1
transaction IRMD Common Stock Tax liability $30,090 -309 -31% $97.38 687 11 Dec 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IRMD Restricted Stock Units Options Exercise $0 -996 -33% $0.000000 1,994 11 Dec 2025 Common Stock 996 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units convert into common stock on a one-for-one basis.
F2 The reporting person received RSUs under Iradimed Corporation's 2023 Equity Incentive Plan. The RSUs vest in three equal annual installments beginning on December 11, 2025. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of RSUs that have vested.